Stichting Lygature

Acronym: LYG

General Information

Identification Code: 319741341874-49

Website: [object Object]

Entity Form: Stichting

Registration Category: Non-governmental organisations, platforms and networks and similar

Registration Date: 3/18/2021

Last Update: 2/27/2024

EP Accredited Number: 0

Mission & Interests

Goals: Our mission is to deliver breakthrough innovations in medical technology and drug development that address unmet medical needs by providing partnership management. We drive partnerships from idea to success by: - Creating a safe space for innovation: We are the independent third party, the neutral enabler - Driving partnerships forward to deliver medical solutions: We focus all our efforts on the success of the partnership - Providing specialized support for partnerships: We deliver dedicated communication, financial and legal support

Interests Represented: Does not represent commercial interests

Interests:

Research and innovation

Levels of Interest:

global

Activities

Main EU Legislative Proposals: Research & innovation in healthcare & life sciences, with a focus on drug discovery & development and medical technology. In particular our interest is in the HorizonEurope framework program, focusing on the Innovative Health Initiative and EDCTP-3

Communication Activities: As Lygature we are involved in various research projects, at the moment in particular projects running within the Innovative Medicines Initiative - 2, the Innovative Health Initiative, and EDCTP-2 and 3

Inter-institutional or Unofficial Groupings: N/A

Head Office

Address: Jaarbeursplein 6

Post Code: 3521 AL

City: Utrecht

Country: NETHERLANDS

Phone: [object Object]

EU Office

Address: Jaarbeursplein 6

Post Code: 3521 AL

City: Utrecht

Country: NETHERLANDS

Phone: [object Object]

Financial Data

New Organisation: false

Closed Year: [object Object]

Current Year: [object Object]

Complementary Information: For current financial year (2024) the amount is the expected budget and includes uncertainties

Membership Information

Members10 Percent: 0

Members25 Percent: 1

Members50 Percent: 0

Members75 Percent: 0

Members: 1

Members F T E: 0.25

Info Members: This number excludes our direct involvement and EU funded activities in the research projects in which we are a partner.

Structure

Structure Type: Structure

Is Member Of: FIGON, the integrative platform for innovative drug research in the Netherlands. https://www.figon.nl/about HollandBIO, Dutch sector organisation (primarily SME's) for innovation in biotech. https://www.hollandbio.nl/

Organisation Members: FIGON, the integrative platform for innovative drug research in the Netherlands. https://www.figon.nl/about HollandBIO, Dutch sector organisation (primarily SME's) for innovation in biotech. https://www.hollandbio.nl/